NYSE Euronext Reports Significant Rise In Trading Volumes for January 2013 - 64% Year on Year Increase

by Andrew Saks McLeod
NYSE Euronext Reports Significant Rise In Trading Volumes for January 2013 - 64% Year on Year Increase

Global Derivatives ADV Up 27% Y‐o‐Y Driven by Strong Fixed Income Trading, Up 64% U.S. Equity Options ADV Up 10% Y‐o‐Y; Record Market Share of 29% U.S. and European Cash ADV Declined Y‐o‐Y But Rebounded from December 2012 levels

NYSE Euronext showed a positive increase in year on year volumes in its announcement of trading volumes for its global derivatives and cash equities exchanges for January 2013. The global derivatives average daily volume (ADV) of 9.5 million contracts demonstrates an overall increase of 26.9% when compared with the previous January.

Stronger fixed income derivatives ADV was a major factor in generating a 27.5% increase in volume in January 2013 when compared with December 2012.

In addition to these stellar figures, NYSE Euronext European derivatives products ADV in January 2013 of 4.9 million contracts increased 51.0% compared to January 2012, and increased 39.4% from December 2012 levels.

With the exception of Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 43.5%

compared to January 2012 and increased 60.8% over the results for December 2012.

NYSE Euronext U.S. equity options maintained an ADV of 4.6 million contracts in January 2013 increased 9.9% compared to January 2012 levels and increased by 17.9% from December 2012 levels.

NYSE Euronext’s U.S. options exchanges accounted for 29.4% of total U.S. consolidated equity options trading in January 2013, setting a new record high.

NYSE Euronext European cash products ADV of 1.3 million transactions in January 2013 decreased 14.4% compared to January 2012 but increased 21.0% compared to December 2012.

NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.6 billion shares in January 2012 decreased 14.4% compared to January 2012 but increased 1.5% compared to December 2012. NYSE Euronext’s Tape A matched market share in January 2013 was 29.7%, down from 30.3% in January 2012 and down from 31.9% in December 2012.

Derivatives Trading

European Derivatives

NYSE Euronext European derivatives products ADV in January 2013 was 4.9 million futures and options contracts, an increase of 51.0% from January 2012 and an increase of 39.4% from December 2012.

The 4.9 million in European derivatives futures and options contracts ADV in November 2012 consisted of 3.8 million contracts executed through NYSE's full‐service.

LIFFE CONNECT Trading Platform and 1.0 million contracts, or 21.1%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.

With the exception of Bclear, European derivatives products ADV increased 43.5% compared to January 2012 and increased 60.8% from December 2012.

Total fixed income products ADV of 3.0 million contracts in January 2013 increased 64.3% from January 2012 and increased 90.8% from December 2012.

Total equity products (including Bclear) ADV of 1.8 million contracts in January 2013 increased 34.2% compared to January 2012 but decreased 3.1% from December 2012.

The 1.8 million contracts in equity products ADV consisted of 1.3 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The closing figure of 1.3 million contracts in individual equity products ADV consisted of 0.8 million in futures contracts, which represented a 97.2% increase compared to January 2012 and 0.5 million in options contracts, which represented a 6.1% decrease compared to

January 2012.

images

Total commodities products ADV was 89,000 contracts in January 2013, an increase of 18.5% compared to January 2012. This however represents a decrease of 8.4% when compared to December 2012.

U.S. Derivatives

NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.6 million contracts in January 2012 increased 9.9% compared to January 2012 and increased 17.9% compared to December 2012.

Total U.S. consolidated equity options ADV decreased 0.5% to 15.6 million contracts in January 2013 compared to January 2012, but increased 9.2% compared to December 2012.

NYSE Euronext’s U.S. options exchanges accounted for 29.4% of the total U.S. consolidated equity options trading in January 2013 a new record high, up from 26.6% in January 2012 and up from 27.2% in December 2012. NYSE Euronext was in first position in terms of market share within the options Exchange group in January.

NYSE Liffe U.S. ADV of approximately 50,900 contracts decreased from 94,900 contracts in January 2012 and decreased from 72,600 contracts in December 2012.

NYSE Euronext Trading Volumes for January 2013 by

Global Derivatives ADV Up 27% Y‐o‐Y Driven by Strong Fixed Income Trading, Up 64% U.S. Equity Options ADV Up 10% Y‐o‐Y; Record Market Share of 29% U.S. and European Cash ADV Declined Y‐o‐Y But Rebounded from December 2012 levels

NYSE Euronext showed a positive increase in year on year volumes in its announcement of trading volumes for its global derivatives and cash equities exchanges for January 2013. The global derivatives average daily volume (ADV) of 9.5 million contracts demonstrates an overall increase of 26.9% when compared with the previous January.

Stronger fixed income derivatives ADV was a major factor in generating a 27.5% increase in volume in January 2013 when compared with December 2012.

In addition to these stellar figures, NYSE Euronext European derivatives products ADV in January 2013 of 4.9 million contracts increased 51.0% compared to January 2012, and increased 39.4% from December 2012 levels.

With the exception of Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 43.5%

compared to January 2012 and increased 60.8% over the results for December 2012.

NYSE Euronext U.S. equity options maintained an ADV of 4.6 million contracts in January 2013 increased 9.9% compared to January 2012 levels and increased by 17.9% from December 2012 levels.

NYSE Euronext’s U.S. options exchanges accounted for 29.4% of total U.S. consolidated equity options trading in January 2013, setting a new record high.

NYSE Euronext European cash products ADV of 1.3 million transactions in January 2013 decreased 14.4% compared to January 2012 but increased 21.0% compared to December 2012.

NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.6 billion shares in January 2012 decreased 14.4% compared to January 2012 but increased 1.5% compared to December 2012. NYSE Euronext’s Tape A matched market share in January 2013 was 29.7%, down from 30.3% in January 2012 and down from 31.9% in December 2012.

Derivatives Trading

European Derivatives

NYSE Euronext European derivatives products ADV in January 2013 was 4.9 million futures and options contracts, an increase of 51.0% from January 2012 and an increase of 39.4% from December 2012.

The 4.9 million in European derivatives futures and options contracts ADV in November 2012 consisted of 3.8 million contracts executed through NYSE's full‐service.

LIFFE CONNECT Trading Platform and 1.0 million contracts, or 21.1%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.

With the exception of Bclear, European derivatives products ADV increased 43.5% compared to January 2012 and increased 60.8% from December 2012.

Total fixed income products ADV of 3.0 million contracts in January 2013 increased 64.3% from January 2012 and increased 90.8% from December 2012.

Total equity products (including Bclear) ADV of 1.8 million contracts in January 2013 increased 34.2% compared to January 2012 but decreased 3.1% from December 2012.

The 1.8 million contracts in equity products ADV consisted of 1.3 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The closing figure of 1.3 million contracts in individual equity products ADV consisted of 0.8 million in futures contracts, which represented a 97.2% increase compared to January 2012 and 0.5 million in options contracts, which represented a 6.1% decrease compared to

January 2012.

images

Total commodities products ADV was 89,000 contracts in January 2013, an increase of 18.5% compared to January 2012. This however represents a decrease of 8.4% when compared to December 2012.

U.S. Derivatives

NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.6 million contracts in January 2012 increased 9.9% compared to January 2012 and increased 17.9% compared to December 2012.

Total U.S. consolidated equity options ADV decreased 0.5% to 15.6 million contracts in January 2013 compared to January 2012, but increased 9.2% compared to December 2012.

NYSE Euronext’s U.S. options exchanges accounted for 29.4% of the total U.S. consolidated equity options trading in January 2013 a new record high, up from 26.6% in January 2012 and up from 27.2% in December 2012. NYSE Euronext was in first position in terms of market share within the options Exchange group in January.

NYSE Liffe U.S. ADV of approximately 50,900 contracts decreased from 94,900 contracts in January 2012 and decreased from 72,600 contracts in December 2012.

NYSE Euronext Trading Volumes for January 2013 by

About the Author: Andrew Saks McLeod
Andrew Saks McLeod
  • 661 Articles
About the Author: Andrew Saks McLeod
  • 661 Articles

More from the Author

Institutional FX

!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}